methylprednisolone IV
Selected indexed studies
- Methylprednisolone, dexamethasone or hydrocortisone for acute severe pediatric asthma: does it matter? (J Asthma, 2022) [PMID:33380248]
- Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database. (BMC Infect Dis, 2025) [PMID:40055601]
- Methylprednisolone aceponate for atopic dermatitis. (Int J Dermatol, 2017) [PMID:28258632]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Methylprednisolone, dexamethasone or hydrocortisone for acute severe pediatric asthma: does it matter? (2022) pubmed
- Effect of methylprednisolone vs hydrocortisone on 30-day mortality in critically ill adults with septic shock: an analysis of the MIMIC-IV database. (2025) pubmed
- Methylprednisolone aceponate for atopic dermatitis. (2017) pubmed
- Methylprednisolone Concentrations in Breast Milk and Serum of Patients with Multiple Sclerosis Treated with IV Pulse Methylprednisolone. (2020) pubmed
- Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions in adults: a randomized controlled trial. (2025) pubmed
- IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS. (2004) pubmed
- Safety of IV pulse methylprednisolone therapy during breastfeeding in patients with multiple sclerosis. (2018) pubmed
- Methylprednisolone dosing for pediatric critical asthma: a single-center cohort study. (2024) pubmed
- Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis. (2023) pubmed
- The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis. (2004) pubmed